Tickers

1. Composite Trajectory Verdict

Given GPOR's capital-intensive E&P model and commodity price sensitivity, all three statements carry roughly equal weight for assessing financial trajectory.

Composite Trajectory: Mixed

Annual 2025 results show significant improvement over 2024 (net income $427.8M vs -$261.4M, operating cash flow $803.2M vs $650.0M, equity up 7.3%). However, the most recent quarter (Q2 2026) shows deterioration versus Q2 2025 (revenue -28%, operating income -49%), while year-to-date 2026 results remain ahead of 2025 (revenue +18%, operating income +35%). The balance sheet shows rising debt ($797M to $930M) and declining liquidity ($806M to $772M) over the first half of 2026, offset by continued equity growth on an annual basis. These conflicting signals across periods and statements yield a mixed trajectory.

2. Red Flags

• Working capital deficit widened slightly to $115.9M at 12/31/2025 from $114.2M at 12/31/2024 (10-K 2025-12-31, Liquidity and Capital Resources).
• Total funded debt increased 16.7% in first half 2026 to $930.0M at 6/30/2026 from $797.0M at 12/31/2025, driven by Credit Facility borrowings rising to $280.0M from $147.0M (10-Q 2026-06-30, Liquidity and Capital Resources; 10-K 2025-12-31, Liquidity and Capital Resources).
• Liquidity declined to $772.4M at 6/30/2026 from $806.1M at 12/31/2025 (10-Q 2026-06-30, 2026 Operational and Financial Highlights; 10-K 2025-12-31, 2025 Operational and Financial Highlights).
• Quarterly revenue and operating income fell sharply in Q2 2026 vs Q2 2025 (revenue -28% to $323.2M, operating income -49% to $127.1M) despite higher oil prices, due to lower gas prices and volumes (10-Q 2026-06-30, Consolidated Statements of Operations; MD&A Comparison of Three Month Periods).
• Free cash flow (operating cash flow less additions to oil and gas properties) decreased 16.5% year-to-date 2026 ($130.0M) vs 2025 ($155.7M) as capital expenditures outpaced operating cash flow growth (10-Q 2026-06-30, Sources and Uses of Cash).
• Large non-cash derivative fair value swings: $42.6M gain in 2025 vs $253.1M loss in 2024, creating volatility in reported earnings (10-K 2025-12-31, Natural Gas, Oil and NGL Derivatives).
• Deemed dividend of $29.9M on preferred redemption reduced net income attributable to common shareholders in 2025 (10-K 2025-12-31, Consolidated Statements of Operations).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Overall Assessment: Full-year 2025 net income of $427.8M represents a substantial improvement from the 2024 net loss of $261.4M, driven by a 48% increase in total revenue to $1,422.6M (10-K 2025-12-31, Consolidated Statements of Operations) and the absence of ceiling test impairments (2024: $373.2M). However, the most recent quarter (Q2 2026) shows a sharp decline versus Q2 2025: total revenue fell 28% to $323.2M, operating income dropped 49% to $127.1M, and income before taxes decreased 53% to $111.1M (10-Q 2026-06-30, Consolidated Statements of Operations). Conversely, year-to-date 2026 results exceed 2025: revenue rose 18% to $760.8M, operating income increased 35% to $354.7M, and income before taxes grew 37% to $321.6M (10-Q 2026-06-30, Consolidated Statements of Operations). The divergence between strong year-to-date performance and weak second-quarter results, combined with the annual rebound from 2024, produces a mixed earnings trajectory.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Overall Assessment: Annual operating cash flow improved 23.6% to $803.2M in 2025 from $650.0M in 2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows), and free cash flow (operating cash flow less additions to oil and gas properties) rose 41% to $275.6M from $195.9M. Year-to-date 2026 operating cash flow increased 8.3% to $442.8M from $408.7M in 2025 (10-Q 2026-06-30, Sources and Uses of Cash). However, capital expenditures accelerated 23.6% to $312.8M year-to-date 2026 from $253.0M in 2025, causing year-to-date free cash flow to decline 16.5% to $130.0M from $155.7M (10-Q 2026-06-30, Sources and Uses of Cash). The company’s Q2 2026 operating cash flow of $149.9M (10-Q 2026-06-30, 2026 Operational and Financial Highlights) lacks a directly comparable prior-year quarter figure in the provided filings. The combination of rising operating cash flow annually and year-to-date, but declining free cash flow year-to-date due to higher investment, yields a mixed cash generation trajectory.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Overall Assessment: The annual balance sheet strengthened from 2024 to 2025: total equity grew 7.3% to $1,834.7M from $1,711.4M despite $336.3M of share repurchases and $32.4M preferred redemption (10-K 2025-12-31, Consolidated Balance Sheets; Consolidated Statements of Stockholders’ Equity). Total funded debt rose modestly to $797.0M from $713.7M, while liquidity remained robust at $806.1M (10-K 2025-12-31, Liquidity and Capital Resources). In the first half of 2026, however, funded debt increased 16.7% to $930.0M at June 30, 2026 (10-Q 2026-06-30, Liquidity and Capital Resources), driven by Credit Facility borrowings rising to $280.0M from $147.0M at year-end 2025 (10-Q 2026-06-30, Liquidity and Capital Resources; 10-K 2025-12-31, Liquidity and Capital Resources). Liquidity declined to $772.4M from $806.1M, and total equity dipped slightly to $1,827.3M from $1,834.7M as share repurchases ($242.8M year-to-date) exceeded year-to-date net income (~$252.9M) (10-Q 2026-06-30, Sources and Uses of Cash; Consolidated Statements of Operations). The annual improvement contrasts with near-term leverage increase and liquidity reduction, resulting in a mixed balance sheet trajectory.

6. Data Gaps

• Standalone Q1 2026 income statement, cash flow, and balance sheet figures (not directly cited in provided 10-Q 2026-03-31 excerpt).
• Q3 2025 and Q1 2025 quarterly financial statements for year-over-year quarterly comparisons beyond Q2.
• Full cash flow statements for Q2 2026 and Q2 2025 (only year-to-date and annual figures provided).
• Realized derivative settlement gains/losses for Q2 2026 and Q2 2025 (only fair value and totals in MD&A).
• Proved reserves PV-10 value for 2025 and 2024 (referenced in supplemental but not in primary financial statements).
• Net debt/EBITDA or leverage ratio calculations (components not fully aligned across periods).
• Current ratio and net funded leverage ratio covenant compliance details for 2026 quarters (only stated as in compliance).